IN2014MN02228A - - Google Patents

Info

Publication number
IN2014MN02228A
IN2014MN02228A IN2228MUN2014A IN2014MN02228A IN 2014MN02228 A IN2014MN02228 A IN 2014MN02228A IN 2228MUN2014 A IN2228MUN2014 A IN 2228MUN2014A IN 2014MN02228 A IN2014MN02228 A IN 2014MN02228A
Authority
IN
India
Prior art keywords
jak2
inden
imidazo
pyrazol
pyridin
Prior art date
Application number
Other languages
English (en)
Inventor
Timothy Paul Burkholder
Joshua Ryan Clayton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IN2014MN02228A publication Critical patent/IN2014MN02228A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN2228MUN2014 2012-06-14 2013-06-05 IN2014MN02228A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261659679P 2012-06-14 2012-06-14
PCT/US2013/044211 WO2013188184A1 (en) 2012-06-14 2013-06-05 Inhibitor of jak1 and jak2

Publications (1)

Publication Number Publication Date
IN2014MN02228A true IN2014MN02228A (da) 2015-07-17

Family

ID=48626679

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2228MUN2014 IN2014MN02228A (da) 2012-06-14 2013-06-05

Country Status (14)

Country Link
US (1) US9062050B2 (da)
EP (1) EP2861231B1 (da)
JP (1) JP6092376B2 (da)
KR (1) KR20150008907A (da)
CN (1) CN104349775B (da)
AU (1) AU2013274641B2 (da)
BR (1) BR112014030651A2 (da)
CA (1) CA2871659C (da)
EA (1) EA201492104A1 (da)
ES (1) ES2605827T3 (da)
IN (1) IN2014MN02228A (da)
MX (1) MX2014015271A (da)
WO (1) WO2013188184A1 (da)
ZA (1) ZA201407940B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR105400A1 (es) * 2015-08-04 2017-09-27 Lilly Co Eli Inhibidores de jak1
EP3942045A1 (en) 2019-03-21 2022-01-26 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
CN110229067A (zh) * 2019-06-05 2019-09-13 南京焕然生物科技有限公司 一种2-氨基茚制备方法
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
CN115141195B (zh) * 2021-03-03 2024-02-06 成都先导药物开发股份有限公司 一种nuak抑制剂及其用途
TW202325289A (zh) * 2021-11-09 2023-07-01 美商雅捷可斯治療公司 Jak2抑制劑之形式及組合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2308731T3 (es) 2005-02-16 2008-12-01 Astrazeneca Ab Compuestos quimicos.
JO3235B1 (ar) 2006-05-26 2018-03-08 Astex Therapeutics Ltd مركبات بيررولوبيريميدين و استعمالاتها
EP2155742A1 (en) * 2007-04-18 2010-02-24 AstraZeneca AB 5-aminopyrazol-3-yl-3h-imidazo [4,5-b]pyridine derivatives and their use for the treatment of cancer

Also Published As

Publication number Publication date
CA2871659C (en) 2017-04-04
JP6092376B2 (ja) 2017-03-08
KR20150008907A (ko) 2015-01-23
EP2861231B1 (en) 2016-08-31
JP2015519396A (ja) 2015-07-09
WO2013188184A1 (en) 2013-12-19
CN104349775A (zh) 2015-02-11
AU2013274641A1 (en) 2014-11-20
CN104349775B (zh) 2017-06-06
US9062050B2 (en) 2015-06-23
ES2605827T3 (es) 2017-03-16
ZA201407940B (en) 2016-05-25
EA201492104A1 (ru) 2015-06-30
EP2861231A1 (en) 2015-04-22
AU2013274641B2 (en) 2015-09-24
CA2871659A1 (en) 2013-12-19
MX2014015271A (es) 2015-03-05
US20150133490A1 (en) 2015-05-14
BR112014030651A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
IN2014MN02228A (da)
PH12014501986A1 (en) 2-amino, 6-phenyl substituted pyrido [2,3-d] pyrimidine derivatives useful as raf kinase inhibitors
IL266170A (en) A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts
MX370814B (es) Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
SG11201907095UA (en) DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
IL266305B (en) History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors
RS61319B1 (sr) Pirazolo[1,5-a]pirimidini korisni kao inhibitori atr kinaze za lečenje kancera
MX2018003861A (es) Nuevos derivados de pirrolo[2,3-d]pirimidina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
PH12018502604A1 (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
PH12019501022A1 (en) Pyrazolopyrimidine compounds and methods of use thereof
MX2017013874A (es) Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa.
IL247948B (en) 7,6,5,4-tetrahydro-pyrazolo[5,1-a]pyrimidine derivatives and 3,2-dihydro-h1-imidazo[2,1-b]pyrazole derivatives as ros1 inhibitors
IL290419A (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
IL268923A (en) History of alicyclic-converted pyrazolo[5,1-a]pyrimidine pharmacological activity
IL280513A (en) Imidazo[2,1-B]pyridazines as TRK inhibitors
PT3679042T (pt) Derivados de imidazo[1,5-a]pirazina como inibidores de pi3kdelta
IL280122A (en) Imidazo[2,1-B]pyridazine derivatives as TRK inhibitors
PL3621966T3 (pl) Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK
LV14663A (lv) Pirolo[1,2-a]hinazolīna atvasinājumu sintēze no N-antranilskābes hidrazīdiem un alfa-ketoskābēm